Beth Kurth


Vice President, Investor Relations

Beth is a financial communications professional who uses her investor relations expertise to ensure clients optimize their interactions with the investment community.   With a focus on credibility and visibility, Beth is committed to positioning clients for success.

Previous Experience

Beth brings 15 years of investor relations expertise including in-house and agency work, across market caps and industries.  She has worked with start-ups and established companies, including biotech, medtech and digital health sectors.

Beth brings strategic insight to her clients, including an assessment of how best to align scientific developments, market positioning and financial metrics.  Through interaction with the investment community, including institutional investors, sell-side analysts and investment bankers, she offers clients real-time feedback and follow-up.

She has strong analytic and authorship skills, including the presentation of data-driven metrics and creation of press releases, IR presentations and Fact Sheets.  She also brings experience developing competitive intelligence programs and interpreting analyst models.

Beth’s background also includes corporate communications where she developed  best-in-class digital, print and social media outreach to enhance visibility for signature one-day financial conference.

Sample Client Representation (past and present)
BioAxone BioSciences Inc
Biotechnology Innovation Organization
Iota Bioscience
LeMaitre Vascular
NewLink Genetics
Newron Pharmaceuticals SpA
Teva Pharmaceuticals
Torreya Insights

Master of Business Administration, Boston University Questrom School of Business, Boston, MA

Bachelor of Arts in English, Tulane University, New Orleans, LA

Finance, literature, politics, science and Boston sports teams

Boston Women in Finance
Financial Executives International
National Investor Relations Institute

Phone: 617-374-8800 x106